Skip to main content

Localisation thoracique

  • Chapter
Book cover Tumeurs malignes rares
  • 54 Accesses

Résumé

Les tumeurs neuro-endocrines bronchopulmonaires sont des tumeurs épithéliales exprimant une différenciation endocrine (1): architecture endocrinoïde, palissadique, trabéculaire, avec images en rosette. Bien que partageant des caractéristiques histopathologiques similaires, ces tumeurs regroupent plusieurs entités cliniques et évolutives distinctes, dispersées au sein de la classification de l’Organisation mondiale de la santé (1), et correspondant à quatre principaux sous-types: les tumeurs carcinoïdes typiques, de bas grade de malignité; les carcinoïdes atypiques, de grade intermédiaire; les carcinomes neuro-endocrines à grandes cellules, de haut grade de malignité; et les carcinomes à petites cellules, de haut grade de malignité (1, 2). Les carcinomes à petites cellules, fréquents (15 à 20% des cancers bronchiques) ne seront pas abordés dans ce chapitre (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Références

  1. Travis WD, Brambilla E, Muller-Hermelink HK, et al. (2004) Pathology and genetics of tumors of the lung, pleura, thymus, and heart. World Health Organization Classification of Tumours. Lyon, IARC Press

    Google Scholar 

  2. Travis WD, Linnoila RI, Tsokos MG, et al. (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15: 529–53

    Article  CAS  PubMed  Google Scholar 

  3. Travis WD, Rush W, Flieder DB, et al. (1998) Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22: 934–44

    Article  CAS  PubMed  Google Scholar 

  4. Davies SJ, Gosney JR, Hansell DM, et al. (2007) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 62: 248–52

    Article  PubMed  Google Scholar 

  5. Hiroshima K, Abe S, Ebihara Y, et al. (2005) Cytological characteristics of pulmonary large cell neuroendocrine carcinoma. Lung Cancer 48: 331–7

    Article  PubMed  Google Scholar 

  6. Garcia-Yuste M, Matilla JM, Alvarez-Gago T, et al. (2000) Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). Ann Thorac Surg 70: 258–63

    Article  CAS  PubMed  Google Scholar 

  7. Iyoda A, Hiroshima K, Toyozaki T, et al. (2001) Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer 91: 1992–2000

    Article  CAS  PubMed  Google Scholar 

  8. Takei H, Asamura H, Maeshima A, et al. (2002) Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 124: 285–92

    Article  PubMed  Google Scholar 

  9. Zacharias J, Nicholson AG, Ladas GP, Goldstraw P (2003) Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg 75: 348–52

    Article  PubMed  Google Scholar 

  10. Paci M, Cavazza A, Annessi V, et al. (2004) Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg 77: 1163–7

    Article  PubMed  Google Scholar 

  11. Asamura H, Kameya T, Matsuno Y, et al. (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24: 70–6

    Article  PubMed  Google Scholar 

  12. Veronesi G, Morandi U, Alloisio M, et al. (2006) Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer 53: 111–5

    Article  PubMed  Google Scholar 

  13. Iyoda A, Hiroshima K, Moriya Y, et al. (2006) Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma. J Thorac Cardiovasc Surg 132: 312–5

    Article  PubMed  Google Scholar 

  14. Rossi G, Cavazza A, Marchioni A, et al. (2005) Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol 23: 8774–85

    Article  CAS  PubMed  Google Scholar 

  15. Iyoda A, Hiroshima K, Moriya Y, et al. (2006) Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann Thorac Surg 82: 1802–7

    Article  PubMed  Google Scholar 

  16. Mazieres J, Daste G, Molinier L, et al. (2002) Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases. Lung Cancer 37: 287–92

    Article  PubMed  Google Scholar 

  17. Fink G, Krelbaum T, Yellin A, et al. (2001) Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 119: 1647–51

    Article  CAS  PubMed  Google Scholar 

  18. Sachithanandan N, Harle RA, Burgess JR (2005) Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer 103: 509–15

    Article  PubMed  Google Scholar 

  19. McDaniel HG, Murad T (1980) Metastatic carcinoid tumor fo the lung producing Cushing’s syndrome. South Med J 73: 1194–7

    CAS  PubMed  Google Scholar 

  20. Chong S, Lee KS, Chung MJ, et al. (2006) Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. Radiographics 26: 41–57

    Article  PubMed  Google Scholar 

  21. Erasmus JJ, McAdams HP, Patz EF Jr, et al. (1998) Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 170: 1369–73

    CAS  PubMed  Google Scholar 

  22. Musi M, Carbone RG, Bertocchi C, et al. (1998) Bronchial carcinoid tumours: a study on clinicopathological features and role of octreotide scintigraphy. Lung Cancer 22: 97–102

    Article  CAS  PubMed  Google Scholar 

  23. Dusmet ME, McKneally MF (1996) Pulmonary and thymic carcinoid tumors. World J Surg 20: 189–95

    Article  CAS  PubMed  Google Scholar 

  24. Marty-Ane CH, Costes V, Pujol JL, et al. (1995) Carcinoid tumors of the lung: do atypical features require aggressive management? Ann Thorac Surg 59: 78–83

    Article  CAS  PubMed  Google Scholar 

  25. Terzi A, Lonardoni A, Falezza G, et al. (2002) Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases. Eur J Cardiothorac Surg 21: 888–93

    Article  CAS  PubMed  Google Scholar 

  26. Bertoletti L, Elleuch R, Kaczmarek D, et al. (2006) Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor. Chest 130: 1405–11

    Article  PubMed  Google Scholar 

  27. Kosmidis PA (2004) Treatment of carcinoid of the lung. Curr Opin Oncol 16: 146–9

    Article  PubMed  Google Scholar 

  28. Beasley MB, Thunnissen FB, Brambilla E, et al. (2000) Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol 31: 1255–65

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Girard, N., Cordier, JF. (2010). Localisation thoracique. In: Tumeurs malignes rares. Springer, Paris. https://doi.org/10.1007/978-2-287-72070-3_35

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72070-3_35

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72069-7

  • Online ISBN: 978-2-287-72070-3

Publish with us

Policies and ethics